 Adjuvant chemotherapy long-term survival patients advanced gastric cancer curative resection effectiveness postoperative adjuvant chemotherapy mitomycin MMC tegafur PSK immunomodulator patients advanced gastric cancer histological curative resection effect chemotherapy prognostic serosal ps invasion ps ps lymph node metastasis eighteen patients no-chemotherapy group drugs median follow-up time survivors time analysis years regard prognostic factors differences groups Wilcoxon test survival patterns value survival rate years patients no-chemotherapy group chemotherapy group particular adjuvant chemotherapy effective patients ps ps ps ps findings concomitant prescription MMC tegafur PSK survival rate patients advanced gastric cancer curative resection survival rate low patients ps aggressive postoperative chemotherapy